CMVM Post Doc Careers Series - David Jenkinson - The Brain Tumour Charity

Event Information

Share this event

Date and Time

Location

Location

Seminar Room

Centre for Regenerative Medicine

Edinburgh BioQuarter

Edinburgh

EH16 4UU

United Kingdom

View Map

Event description

Description

In the second issue of the postdoctoral career symposia series, The University of Edinburgh welcomes Dr David Jenkinson, Chief Scientific Officer of The Brain Tumour Charity.

Image result for david jenkinson brain tumour charity

With over 20 years’ experience in oncology research, starting life as a Post Doc researcher examining the role of migration in cancer development and metastasis, working in spin out companies and then becoming Chief Scientific Officer for The Brain Tumour Charity. David has had a varied career path and will provide us with an open and honest account of his career journey.

David started by gaining a degree in biochemistry from Brunel University. He undertook a PhD at University of London studying the role of N-RAS in acute myeloid leukaemia, before joining Professor Ian Hart at the Richard Dimbleby/ICRF laboratory as a postdoctoral researcher, examining the role of migration in cancer development and metastasis.

David then joined Gene Expression Technologies, a spin-out from Imperial College, where he led the biology at a company, developing therapeutics to control the expression of genes in cancer. Despite the company’s funding expiring, the work that David led resulted in successful applications to Cancer Research UK’s Discovery Committee for continued funding through academic researchers.

David moved to Cancer Research Technology where he gained experience in technology assessment, protection, development and licensing. Whilst in this post, he introduced several innovative approaches to ensure progression of discoveries towards patients, including securing orphan designations, industry co-funding agreements and the establishment of industry-academia drug discovery alliances.

David joined The Brain Tumour Charity in 2016 where he leads the research team and is responsible for delivering the research strategy to Double Survival and Halve the Harm. In this role he has been responsible for ensuring the best quality research is funded by adopting a global outlook on research to defeat brain tumours. He is also responsible for exploring new models of research investment to accelerate progress in area, and has recently led the partnering with the Center for Advancing Innovation to incubate start-ups in the field. He has also led on the establishment of the Brain tumouR Information Analysis Network (BRIAN) and the Tessa Jowell BRAIN-MATRIX platform trial for glioma.

David has a passion for ensuring basic research is translated for patient benefit and tumours are spotted at a stage where they are more easily treatable. He brings a collaborative approach and is determined to make a difference for those affected by these brain tumours.

The seminar will be followed by a drinks reception and networking opportunity.

Date and Time

Location

Seminar Room

Centre for Regenerative Medicine

Edinburgh BioQuarter

Edinburgh

EH16 4UU

United Kingdom

View Map

Save This Event

Event Saved